| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19,000 | 13 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | 13 May 2025 | 1 | $0 | 4 | Director | 14 May 2025, 16:33 |
| LRMR | Larimar Therapeutics, Inc. | 29 May 2024 | 1 | $0 | 4 | Director | 31 May 2024, 16:57 |
| LRMR | Larimar Therapeutics, Inc. | 17 May 2023 | 1 | +$10,258 | 4 | Director | 18 May 2023, 14:12 |
| LRMR | Larimar Therapeutics, Inc. | 09 May 2023 | 1 | $0 | 4 | Director | 11 May 2023, 16:29 |
| LRMR | Larimar Therapeutics, Inc. | 10 May 2022 | 1 | $0 | 4 | Director | 12 May 2022, 20:28 |
| LRMR | Larimar Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 08:48 |